Business / Financial Markets Jan 10, 2023
Eisai shares jump after FDA approves Alzheimer’s drug lecanemab
by Kanoko Matsuyama
The drug, to be sold under the brand name Leqembi, was approved by the Food and Drug Administration under an accelerated pathway.
